CXCR1 and neoplasm: Importantly, at a dose of 2.5 μmol/L, C29 did not affect the proliferation/survival of uveal melanoma cells (Mel202), which is consistent with a low level of expression of CXCR1/2 in this tumor type (Figure S2 and S4).